Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Retraction: Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.
Journal: Oncotarget
Published: July 21, 2026
Progestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.
Journal: Gynecologic oncology
Published: October 23, 2025
Behavioral reactivity to ecological momentary assessment of alcohol and sexual assault protective behavioral strategies.
Journal: Experimental and clinical psychopharmacology
Published: October 20, 2025
Retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP.
Journal: Oncotarget
Published: July 30, 2025
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial.
Journal: Gynecologic oncology
Published: October 08, 2024
Patient engagement in designing and publishing research in prostate cancer: a scoping review.
Journal: Future oncology (London, England)
Published: April 04, 2024
The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma.
The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma.
Journal: Gynecologic oncology
Published: December 08, 2023
Surviving and thriving: What do survivors of gynecologic cancer want?
Journal: Gynecologic oncology reports
Published: March 28, 2022
Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.
Journal: American journal of obstetrics and gynecology
Published: November 22, 2021
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.
Journal: Communications biology
Published: November 15, 2021
Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: July 29, 2021
Last Updated: 09/26/2026